Decreased severity of COVID-19 in vaccinated pregnant individuals during predominance of different SARS-CoV-2 variants
- PMID: 35789021
- PMCID: PMC9349799
- DOI: 10.1111/aji.13596
Decreased severity of COVID-19 in vaccinated pregnant individuals during predominance of different SARS-CoV-2 variants
Abstract
Problem: Since the start of the pandemic, Pregnant individuals have been disproportionately affected by the severe acute respiratory syndrome coronavirus 2. Vaccination has been shown to be protective against severe disease. However, data on effectiveness of vaccine in reducing disease severity are limited in pregnant individuals who later developed COVID-19.
Method of study: This is a single academic center retrospective cohort study of pregnant individuals who tested positive for COVID-19 from December 2020 through January 2022. The cohort was divided into two groups based on vaccination status. The primary outcome of our study was progression to severe or critical disease. A secondary analysis was performed based on the timeframes of predominance of different variants of SARS-CoV-2, to determine whether the effect of vaccination was different during these epochs.
Results: Our cohort included 472 patients among which 125 (26.5%) were vaccinated and 347 were unvaccinated. None of the patients in the vaccinated group who later developed COVID-19 progressed to severe or critical disease compared to 7.2% in the unvaccinated one (p < .01). Similarly, after adjusting for medical comorbidities, obesity, receipt of monoclonal antibodies, and trimester at diagnosis, vaccinated individuals who later developed COVID-19 were less likely to be admitted to the hospital (1.6% vs. 14.7%, aOR .14, 95% CI .22-.47) compared with unvaccinated ones.
Conclusion: Vaccination against SARS-CoV-2 in pregnant individuals who later develop a breakthrough infection, is associated with decreased progression to severe or critical COVID-19, and need for hospital and ICU admissions. Vaccination is specifically effective during the predominance of the more severe Delta variant.
Keywords: COVID-19; SARS-CoV-2 variants; pregnancy; vaccination.
© 2022 The Authors. American Journal of Reproductive Immunology published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors have no conflicts of interest or financial disclosures.
Figures
Similar articles
-
Vaccination options for pregnant women during the Omicron period.J Reprod Immunol. 2023 Mar;156:103798. doi: 10.1016/j.jri.2023.103798. Epub 2023 Jan 6. J Reprod Immunol. 2023. PMID: 36640675 Free PMC article. Review.
-
Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.JAMA. 2021 Aug 24;326(8):728-735. doi: 10.1001/jama.2021.11035. JAMA. 2021. PMID: 34251417 Free PMC article.
-
Reduced control of SARS-CoV-2 infection associates with lower mucosal antibody responses in pregnancy.mSphere. 2024 Mar 26;9(3):e0081223. doi: 10.1128/msphere.00812-23. Epub 2024 Mar 1. mSphere. 2024. PMID: 38426787 Free PMC article.
-
SARS-CoV-2 vaccine effectiveness in preventing confirmed infection in pregnant women.J Clin Invest. 2021 Dec 1;131(23):e153662. doi: 10.1172/JCI153662. J Clin Invest. 2021. PMID: 34618693 Free PMC article.
-
Increasing rates of sars-cov-2 infection in newborns during the omicron variant epoch.Am J Reprod Immunol. 2023 Aug;90(2):e13742. doi: 10.1111/aji.13742. Am J Reprod Immunol. 2023. PMID: 37491920 Review.
Cited by
-
The impact of maternal SARS-CoV-2 infection and COVID-19 vaccination on maternal-fetal outcomes.Reprod Toxicol. 2022 Dec;114:33-43. doi: 10.1016/j.reprotox.2022.10.003. Epub 2022 Oct 22. Reprod Toxicol. 2022. PMID: 36283657 Free PMC article. Review.
-
Vaccination options for pregnant women during the Omicron period.J Reprod Immunol. 2023 Mar;156:103798. doi: 10.1016/j.jri.2023.103798. Epub 2023 Jan 6. J Reprod Immunol. 2023. PMID: 36640675 Free PMC article. Review.
-
Comparison of Maternal-Fetal Outcomes among Unvaccinated and Vaccinated Pregnant Women with COVID-19.J Pers Med. 2022 Dec 3;12(12):2008. doi: 10.3390/jpm12122008. J Pers Med. 2022. PMID: 36556229 Free PMC article.
-
Association of Infection with Different SARS-CoV-2 Variants during Pregnancy with Maternal and Perinatal Outcomes: A Systematic Review and Meta-Analysis.Int J Environ Res Public Health. 2022 Nov 29;19(23):15932. doi: 10.3390/ijerph192315932. Int J Environ Res Public Health. 2022. PMID: 36498007 Free PMC article.
-
Pregnancy and COVID-19: past, present and future.Obstet Gynecol Sci. 2023 May;66(3):149-160. doi: 10.5468/ogs.23001. Epub 2023 Mar 20. Obstet Gynecol Sci. 2023. PMID: 36938588 Free PMC article.
References
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous